{"id":6067,"date":"2020-07-09T10:36:52","date_gmt":"2020-07-09T09:36:52","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=6067"},"modified":"2020-07-09T10:36:52","modified_gmt":"2020-07-09T09:36:52","slug":"caring-for-children-with-cancer-during-the-covid-19-pandemic","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/caring-for-children-with-cancer-during-the-covid-19-pandemic\/6067\/","title":{"rendered":"Caring for children with cancer during the COVID-19 pandemic"},"content":{"rendered":"
The consequences of the COVID-19 pandemic<\/a> have implications for children and adolescents with cancer and how we can ensure the best possible diagnosis, treatment, and follow-up for them. It is now more important than ever to continue to monitor and share experiences and expertise in caring for children with cancer during the COVID-19 pandemic.<\/p>\n The European Society for Paediatric Oncology (SIOP Europe) has worked in close collaboration with the International Society of Paediatric Oncology (SIOP) and the other key global Societies representing the needs of children and adolescents with cancer to generate a paper<\/a> entitled \u2018The COVID-19 PANDEMIC: A Rapid Global response for Children with Cancer from SIOP, COG, SIOP Europe, SIOP-PODC, IPSO, PROS, CCI and St Jude Global\u2019 which has been published in the journal Pediatric Blood and Cancer (the article is also online https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/pbc.28409<\/a>).<\/p>\n This Special Report gives a summary of the broad principles for continuing multidisciplinary care during SARS-CoV-2 (COVID-19) and articulates the framework for healthcare teams caring for children with cancer during the pandemic, with contributions from the leadership of the International Society for Paediatric Oncology (SIOP), Children\u2019s Oncology Group (COG), St Jude Global programme, and Childhood Cancer International.<\/p>\n Since it is anticipated that the burden will be heaviest on children, their families, and cancer care services in low- and middle-income countries during this global health emergency, the relevant clinical leads from SIOP, SIOP Europe, COG, and SIOP-PODC (Paediatric Oncology in Developing Countries) were brought together to focus on the six most curable cancers. The most curable cancers are: Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, Hodgkin Lymphoma, Retinoblastoma, Wilms Tumour, ans Low Grade Glioma.<\/p>\n The overall message is that planned diagnostics and treatment of children with cancer should continue to be delivered in a timely way, with as few modifications as possible whilst considering patient safety and service constraints. The article provides useful guidance and recommendations for adapting diagnostic and treatment protocols for children with cancer during this pandemic, containment measures (i.e. social distancing, shielding) and how to prepare for the recovery period.<\/p>\n During these unprecedented times, it is my hope that the guidance in this publication will provide practical solutions for the issues that are facing our medical and nursing colleagues who care for children and adolescents with cancer across the world.<\/p>\n I would like to thank all our colleagues for the swift co-operation to create this publication and I trust that everyone will be able to continue caring for patients and their families whilst keeping safe.<\/p>\n Professor Pamela Kearns <\/strong>A global response<\/h3>\n
The six most curable cancers<\/h3>\n
Guidance and recommendations<\/h3>\n
Practical solutions<\/h3>\n
\nPresident<\/strong>
\nSIOP Europe <\/strong>
\noffice@siope.eu<\/strong><\/a>
\nTweet @SIOPEurope<\/a><\/strong>
\nwww.siope.eu<\/strong><\/a><\/p>\n